Inactivated Influenza Vaccine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Inactivated Influenza Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Inactivated Influenza Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Inactivated Influenza Vaccine Overall Market Size
2.1 Global Inactivated Influenza Vaccine Market Size: 2021 VS 2028
2.2 Global Inactivated Influenza Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Inactivated Influenza Vaccine Sales: 2017-2028
3 Company Landscape
3.1 Top Inactivated Influenza Vaccine Players in Global Market
3.2 Top Global Inactivated Influenza Vaccine Companies Ranked by Revenue
3.3 Global Inactivated Influenza Vaccine Revenue by Companies
3.4 Global Inactivated Influenza Vaccine Sales by Companies
3.5 Global Inactivated Influenza Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Inactivated Influenza Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Inactivated Influenza Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Inactivated Influenza Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Inactivated Influenza Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Inactivated Influenza Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Inactivated Influenza Vaccine Market Size Markets, 2021 & 2028
4.1.2 Trivalent Influenza Vaccine
4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type - Global Inactivated Influenza Vaccine Revenue & Forecasts
4.2.1 By Type - Global Inactivated Influenza Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Inactivated Influenza Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Inactivated Influenza Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Inactivated Influenza Vaccine Sales & Forecasts
4.3.1 By Type - Global Inactivated Influenza Vaccine Sales, 2017-2022
4.3.2 By Type - Global Inactivated Influenza Vaccine Sales, 2023-2028
4.3.3 By Type - Global Inactivated Influenza Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Inactivated Influenza Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Inactivated Influenza Vaccine Market Size, 2021 & 2028
5.1.2 Children
5.1.3 Adolescence
5.1.4 Adults
5.1.5 Elderly
5.2 By Application - Global Inactivated Influenza Vaccine Revenue & Forecasts
5.2.1 By Application - Global Inactivated Influenza Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Inactivated Influenza Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Inactivated Influenza Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Inactivated Influenza Vaccine Sales & Forecasts
5.3.1 By Application - Global Inactivated Influenza Vaccine Sales, 2017-2022
5.3.2 By Application - Global Inactivated Influenza Vaccine Sales, 2023-2028
5.3.3 By Application - Global Inactivated Influenza Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Inactivated Influenza Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Inactivated Influenza Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Inactivated Influenza Vaccine Revenue & Forecasts
6.2.1 By Region - Global Inactivated Influenza Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Inactivated Influenza Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Inactivated Influenza Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Inactivated Influenza Vaccine Sales & Forecasts
6.3.1 By Region - Global Inactivated Influenza Vaccine Sales, 2017-2022
6.3.2 By Region - Global Inactivated Influenza Vaccine Sales, 2023-2028
6.3.3 By Region - Global Inactivated Influenza Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Inactivated Influenza Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Inactivated Influenza Vaccine Sales, 2017-2028
6.4.3 US Inactivated Influenza Vaccine Market Size, 2017-2028
6.4.4 Canada Inactivated Influenza Vaccine Market Size, 2017-2028
6.4.5 Mexico Inactivated Influenza Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Inactivated Influenza Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Inactivated Influenza Vaccine Sales, 2017-2028
6.5.3 Germany Inactivated Influenza Vaccine Market Size, 2017-2028
6.5.4 France Inactivated Influenza Vaccine Market Size, 2017-2028
6.5.5 U.K. Inactivated Influenza Vaccine Market Size, 2017-2028
6.5.6 Italy Inactivated Influenza Vaccine Market Size, 2017-2028
6.5.7 Russia Inactivated Influenza Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Inactivated Influenza Vaccine Market Size, 2017-2028
6.5.9 Benelux Inactivated Influenza Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Inactivated Influenza Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Inactivated Influenza Vaccine Sales, 2017-2028
6.6.3 China Inactivated Influenza Vaccine Market Size, 2017-2028
6.6.4 Japan Inactivated Influenza Vaccine Market Size, 2017-2028
6.6.5 South Korea Inactivated Influenza Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Inactivated Influenza Vaccine Market Size, 2017-2028
6.6.7 India Inactivated Influenza Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Inactivated Influenza Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Inactivated Influenza Vaccine Sales, 2017-2028
6.7.3 Brazil Inactivated Influenza Vaccine Market Size, 2017-2028
6.7.4 Argentina Inactivated Influenza Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Inactivated Influenza Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Inactivated Influenza Vaccine Sales, 2017-2028
6.8.3 Turkey Inactivated Influenza Vaccine Market Size, 2017-2028
6.8.4 Israel Inactivated Influenza Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Inactivated Influenza Vaccine Market Size, 2017-2028
6.8.6 UAE Inactivated Influenza Vaccine Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 CSL Limited
7.1.1 CSL Limited Corporate Summary
7.1.2 CSL Limited Business Overview
7.1.3 CSL Limited Inactivated Influenza Vaccine Major Product Offerings
7.1.4 CSL Limited Inactivated Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 CSL Limited Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Inactivated Influenza Vaccine Major Product Offerings
7.2.4 GSK Inactivated Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 GSK Key News
7.3 Sanofi Pasteur
7.3.1 Sanofi Pasteur Corporate Summary
7.3.2 Sanofi Pasteur Business Overview
7.3.3 Sanofi Pasteur Inactivated Influenza Vaccine Major Product Offerings
7.3.4 Sanofi Pasteur Inactivated Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Sanofi Pasteur Key News
7.4 Viatris
7.4.1 Viatris Corporate Summary
7.4.2 Viatris Business Overview
7.4.3 Viatris Inactivated Influenza Vaccine Major Product Offerings
7.4.4 Viatris Inactivated Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Viatris Key News
7.5 Hualan Biological
7.5.1 Hualan Biological Corporate Summary
7.5.2 Hualan Biological Business Overview
7.5.3 Hualan Biological Inactivated Influenza Vaccine Major Product Offerings
7.5.4 Hualan Biological Inactivated Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Hualan Biological Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Inactivated Influenza Vaccine Major Product Offerings
7.6.4 AstraZeneca Inactivated Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 AstraZeneca Key News
7.7 Sinovac Biotech
7.7.1 Sinovac Biotech Corporate Summary
7.7.2 Sinovac Biotech Business Overview
7.7.3 Sinovac Biotech Inactivated Influenza Vaccine Major Product Offerings
7.7.4 Sinovac Biotech Inactivated Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Sinovac Biotech Key News
7.8 Aleph Biomedical
7.8.1 Aleph Biomedical Corporate Summary
7.8.2 Aleph Biomedical Business Overview
7.8.3 Aleph Biomedical Inactivated Influenza Vaccine Major Product Offerings
7.8.4 Aleph Biomedical Inactivated Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Aleph Biomedical Key News
7.9 Abbott Laboratories
7.9.1 Abbott Laboratories Corporate Summary
7.9.2 Abbott Laboratories Business Overview
7.9.3 Abbott Laboratories Inactivated Influenza Vaccine Major Product Offerings
7.9.4 Abbott Laboratories Inactivated Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Abbott Laboratories Key News
7.10 Novartis International
7.10.1 Novartis International Corporate Summary
7.10.2 Novartis International Business Overview
7.10.3 Novartis International Inactivated Influenza Vaccine Major Product Offerings
7.10.4 Novartis International Inactivated Influenza Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Novartis International Key News
8 Global Inactivated Influenza Vaccine Production Capacity, Analysis
8.1 Global Inactivated Influenza Vaccine Production Capacity, 2017-2028
8.2 Inactivated Influenza Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Inactivated Influenza Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Inactivated Influenza Vaccine Supply Chain Analysis
10.1 Inactivated Influenza Vaccine Industry Value Chain
10.2 Inactivated Influenza Vaccine Upstream Market
10.3 Inactivated Influenza Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Inactivated Influenza Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Inactivated Influenza Vaccine in Global Market
Table 2. Top Inactivated Influenza Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Inactivated Influenza Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Inactivated Influenza Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Inactivated Influenza Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Inactivated Influenza Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Inactivated Influenza Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Inactivated Influenza Vaccine Product Type
Table 9. List of Global Tier 1 Inactivated Influenza Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inactivated Influenza Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Inactivated Influenza Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Inactivated Influenza Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Inactivated Influenza Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Inactivated Influenza Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Inactivated Influenza Vaccine Sales (K Units), 2023-2028
Table 16. By Application ? Global Inactivated Influenza Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Inactivated Influenza Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Inactivated Influenza Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Inactivated Influenza Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Inactivated Influenza Vaccine Sales (K Units), 2023-2028
Table 21. By Region ? Global Inactivated Influenza Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Inactivated Influenza Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Inactivated Influenza Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Inactivated Influenza Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Inactivated Influenza Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Inactivated Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Inactivated Influenza Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Inactivated Influenza Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Inactivated Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Inactivated Influenza Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Inactivated Influenza Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Inactivated Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Inactivated Influenza Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Inactivated Influenza Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Inactivated Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Inactivated Influenza Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Inactivated Influenza Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Inactivated Influenza Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Inactivated Influenza Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Inactivated Influenza Vaccine Sales, (K Units), 2023-2028
Table 46. CSL Limited Corporate Summary
Table 47. CSL Limited Inactivated Influenza Vaccine Product Offerings
Table 48. CSL Limited Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. GSK Corporate Summary
Table 50. GSK Inactivated Influenza Vaccine Product Offerings
Table 51. GSK Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Sanofi Pasteur Corporate Summary
Table 53. Sanofi Pasteur Inactivated Influenza Vaccine Product Offerings
Table 54. Sanofi Pasteur Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Viatris Corporate Summary
Table 56. Viatris Inactivated Influenza Vaccine Product Offerings
Table 57. Viatris Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Hualan Biological Corporate Summary
Table 59. Hualan Biological Inactivated Influenza Vaccine Product Offerings
Table 60. Hualan Biological Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. AstraZeneca Corporate Summary
Table 62. AstraZeneca Inactivated Influenza Vaccine Product Offerings
Table 63. AstraZeneca Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Sinovac Biotech Corporate Summary
Table 65. Sinovac Biotech Inactivated Influenza Vaccine Product Offerings
Table 66. Sinovac Biotech Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Aleph Biomedical Corporate Summary
Table 68. Aleph Biomedical Inactivated Influenza Vaccine Product Offerings
Table 69. Aleph Biomedical Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Abbott Laboratories Corporate Summary
Table 71. Abbott Laboratories Inactivated Influenza Vaccine Product Offerings
Table 72. Abbott Laboratories Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Novartis International Corporate Summary
Table 74. Novartis International Inactivated Influenza Vaccine Product Offerings
Table 75. Novartis International Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Inactivated Influenza Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Inactivated Influenza Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Inactivated Influenza Vaccine Production by Region, 2017-2022 (K Units)
Table 79. Global Inactivated Influenza Vaccine Production by Region, 2023-2028 (K Units)
Table 80. Inactivated Influenza Vaccine Market Opportunities & Trends in Global Market
Table 81. Inactivated Influenza Vaccine Market Drivers in Global Market
Table 82. Inactivated Influenza Vaccine Market Restraints in Global Market
Table 83. Inactivated Influenza Vaccine Raw Materials
Table 84. Inactivated Influenza Vaccine Raw Materials Suppliers in Global Market
Table 85. Typical Inactivated Influenza Vaccine Downstream
Table 86. Inactivated Influenza Vaccine Downstream Clients in Global Market
Table 87. Inactivated Influenza Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Inactivated Influenza Vaccine Segment by Type
Figure 2. Inactivated Influenza Vaccine Segment by Application
Figure 3. Global Inactivated Influenza Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Inactivated Influenza Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Inactivated Influenza Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Inactivated Influenza Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Inactivated Influenza Vaccine Revenue in 2021
Figure 9. By Type - Global Inactivated Influenza Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Inactivated Influenza Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Inactivated Influenza Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Inactivated Influenza Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Inactivated Influenza Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Inactivated Influenza Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Inactivated Influenza Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Inactivated Influenza Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Inactivated Influenza Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Inactivated Influenza Vaccine Sales Market Share, 2017-2028
Figure 19. US Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Inactivated Influenza Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Inactivated Influenza Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Inactivated Influenza Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Inactivated Influenza Vaccine Sales Market Share, 2017-2028
Figure 33. China Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Inactivated Influenza Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Inactivated Influenza Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Inactivated Influenza Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Inactivated Influenza Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Inactivated Influenza Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Inactivated Influenza Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Inactivated Influenza Vaccine by Region, 2021 VS 2028
Figure 50. Inactivated Influenza Vaccine Industry Value Chain
Figure 51. Marketing Channels
Industry Market Size
